Literature DB >> 18608208

Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress.

Claudia A Sánchez1, Emma Rodríguez, Elvira Varela, Estrella Zapata, Araceli Páez, Felipe A Massó, Luis F Montaño, Rebeca Lóopez-Marure.   

Abstract

Statins have antiproliferative and anti-tumoral effects in MCF-7 cells. We determined the effect of statins upon MCF-7 cell cycle, toxicity, cell death, reactive oxygen species (ROS) production and mitochondrial membrane potential. Fluvastatin, simvastatin and atorvastatin inhibited cell proliferation. Antiproliferation was associated with a decrease in the DNA synthesis and a cell cycle arrest in the G1 and G2/M phases. A loss in the mitochondrial membrane potential was observed with fluvastatin. Statins induced increase in ROS production that was associated with cell death, which was abrogated by the antioxidant NAC. Our results suggest that the cytotoxic effect observed is mediated by an oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18608208     DOI: 10.1080/07357900701874658

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  40 in total

Review 1.  Is immunity a mechanism contributing to statin-induced diabetes?

Authors:  Brandyn D Henriksbo; Jonathan D Schertzer
Journal:  Adipocyte       Date:  2015-04-20       Impact factor: 4.534

2.  Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro.

Authors:  Hannah M Jones; Ziwei Fang; Wenchuan Sun; Leslie H Clark; Jessica E Stine; Arthur-Quan Tran; Stephanie A Sullivan; Timothy P Gilliam; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

3.  On the combined effect of statins and lycopene on cytokine production by human peripheral blood cells.

Authors:  Michael Bergman; Meir Djaldetti; Hertzel Salman; Hanna Bessler
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

Review 4.  JNK signaling as a target for anticancer therapy.

Authors:  Kamal S Abdelrahman; Heba A Hassan; Salah A Abdel-Aziz; Adel A Marzouk; Atsushi Narumi; Hiroyuki Konno; Mohamed Abdel-Aziz
Journal:  Pharmacol Rep       Date:  2021-03-12       Impact factor: 3.024

5.  Atorvastatin up-regulate toxicologically relevant genes in rainbow trout gills.

Authors:  Kathrin Sabine Ellesat; Tor Fredrik Holth; Marcin Włodzimierz Wojewodzic; Ketil Hylland
Journal:  Ecotoxicology       Date:  2012-05-04       Impact factor: 2.823

6.  Simvastatin alleviates cardiac fibrosis induced by infarction via up-regulation of TGF-β receptor III expression.

Authors:  Fei Sun; Wenqi Duan; Yu Zhang; Lingling Zhang; Muge Qile; Zengyan Liu; Fang Qiu; Dan Zhao; Yanjie Lu; Wenfeng Chu
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

7.  Effects of lovastatin on breast cancer cells: a proteo-metabonomic study.

Authors:  Jelena Klawitter; Touraj Shokati; Vanessa Moll; Uwe Christians; Jost Klawitter
Journal:  Breast Cancer Res       Date:  2010-03-05       Impact factor: 6.466

8.  Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer.

Authors:  Monica N Schointuch; Timothy P Gilliam; Jessica E Stine; Xiaoyun Han; Chunxiao Zhou; Paola A Gehrig; Kenneth Kim; Victoria L Bae-Jump
Journal:  Gynecol Oncol       Date:  2014-05-28       Impact factor: 5.482

Review 9.  Cancer prevention with promising natural products: mechanisms of action and molecular targets.

Authors:  Poyil Pratheeshkumar; Chakkenchath Sreekala; Zhuo Zhang; Amit Budhraja; Songze Ding; Young-Ok Son; Xin Wang; Andrew Hitron; Kim Hyun-Jung; Lei Wang; Jeong-Chae Lee; Xianglin Shi
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

10.  Statins decrease the expression of c-Myc protein in cancer cell lines.

Authors:  Prema S Rao; U Subrahmanyeswara Rao
Journal:  Mol Cell Biochem       Date:  2020-10-17       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.